**Author details**

Saadat Huseynova1 \*, Jamila Gurbanova1 , Afat Hasanova1 , Samaya Alizada1 and Nushaba Panakhova2

1 Scientific Research Institute of Obstetrics and Gynecology, Baku, Azerbaijan

2 Pediatrics Department of Azerbaijan Medical University, Baku, Azerbaijan

\*Address all correspondence to: sadi\_0105@mail.ru

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**130**

**Acknowledgements**

**Table 2.**

**Conflict of interest**

The authors declare no conflict of interests.

The authors sincerely thank Science Development Foundation under the President of the Azerbaijan Republic for providing specific reagent kits (Grant SDF-2010-1(1)-40/28-M-2). We also thank the staff of the Clinical Biochemistry Laboratory of Azerbaijan Medical University for assistance with biomarker analysis.

*Blood concentrations of vasoregulatory markers in the early neonatal period by study groups. 1st group: HIE infants diagnosed with moderate-to-severe neurodevelopmental disorders or cerebral palsy; 2nd group: HIE infants with mild neurologic changes at an early age; 3rd group: HIE infants without evidence of neurological* 

*significant between main groups (1-2, 1-3, 2-3), and between main and control groups (1-c, 2-c, 3-c).*

*p<0,05 is considered statistically* 

*impairment in the post-neonatal period; control group: healthy preterm infants. a*

*Basic and Clinical Understanding of Microcirculation*
